Concepedia

Publication | Open Access

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

DOIFull Paper Access

64

Citations

28

References

2021

Year

Roberto Alva‐Ruiz, Lavanya Yohanathan, Jennifer A. Yonkus, Amro M. Abdelrahman, Lindsey A. Gregory, T.R. Halfdanarson, Amit Mahipal, Robert R. McWilliams, Wen Wee, Christopher L. Hallemeier,
Annals of Surgical Oncology

Abstract

CS in patients undergoing NAC for BR/LA pancreatic cancer does not incur oncologic detriment. The incorporation of CS into NAC treatment sequencing may allow a greater proportion of patients to proceed to curative-intent surgery.

References

YearCitations

Page 1